Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Intervalo de año de publicación
1.
Res Vet Sci ; 132: 268-270, 2020 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-32693251

RESUMEN

Helminths have developed complex mechanisms to suppress the host immune response. These mechanisms may impair the host vaccine response. This study aimed to evaluate the effect of Toxocara spp. infection on the vaccine immune response to bovine herpesvirus type 5 (BoHV-5). First, 30 heifers received two doses of an experimental BoHV-5 vaccine. At 42nd days after the primo vaccination the vaccine efficacy was evaluated, and the presence of anti-Toxocara antibodies. Second, 20 Balb/c mice were divided into two groups, one infected with T. canis and the other without infection. After infection, both groups received two doses of vaccine. The vaccine immune response was assessed by BoHV-5 serum neutralization and splenic cytokines transcription by qPCR. All heifers positive for Toxocara spp. (40%) showed BoHV-5 SN titer ≤1:32, whereas heifers negative for Toxocara spp. (60%) had BoHV-5 SN titer ≥1: 128. Infected T. canis mice showed BoHV-5 SN titer ≤1:2, whereas mice not infected with T. canis BoHV-5 SN titer ≥1:8. Splenocytes from control mice stimulated with BoHV-5 had a significant (p < .05) mRNA transcription for the cytokines IL-12, IL-17, and IL-23, whereas the same cytokines were down-regulated in T. canis infected mice. These results suggest that Toxocara spp. infection may impair BoHV-5 immunization and should be considered for efficient herd immunization.


Asunto(s)
Enfermedades de los Bovinos/prevención & control , Infecciones por Herpesviridae/veterinaria , Herpesvirus Bovino 5 , Toxocara canis , Toxocariasis/patología , Animales , Bovinos , Enfermedades de los Bovinos/inmunología , Femenino , Infecciones por Herpesviridae/prevención & control , Ratones , Bazo , Toxocariasis/inmunología , Vacunación/veterinaria
2.
Arq. bras. med. vet. zootec. (Online) ; 72(3): 703-710, May-June, 2020. ilus, graf
Artículo en Portugués | LILACS, VETINDEX | ID: biblio-1128856

RESUMEN

O herpesvírus equídeo 1 (EHV-1) apresenta distribuição mundial e causa graves prejuízos à equideocultura. É agente de surtos de doença respiratória, reprodutiva e neurológica, em equídeos jovens e adultos. A glicoproteína D (gD) do envelope viral é essencial para ligação e penetração em células permissivas e direcionamento do sistema imunológico do hospedeiro, induz respostas imunes humorais e celulares, sendo um antígeno apropriado para ser utilizado em vacinas e imunodiagnóstico. O objetivo deste trabalho foi expressar e caracterizar a gD do EHV-1 em Pichia pastoris para posterior utilização como antígeno em técnicas de imunodiagnóstico e formulação de vacinas recombinantes. Uma sequência de DNA que codifica uma forma truncada da gDEHV-1 foi clonada no vetor pPICZαA de expressão em P. pastoris. Obteve-se uma proteína de ~41 kDa, como esperado. A proteína apresentou glicosilação entre 4 kDa e 16 kDa, demonstrada por deglicosilação enzimática. A proteína recombinante foi caracterizada antigenicamente e imunogenicamente por Western blot, utilizando-se anticorpos policlonais equinos anti-EHV-1, e por ELISA indireto em modelo murino, demonstrando que a gD recombinante manteve epítopos similares aos da proteína nativa. Esses resultados sugerem que a gDEHV-1 é um antígeno promissor para uso como imunobiológico no controle do EHV-1.(AU)


Equine herpesvirus 1 (EHV-1) has a worldwide distribution and causes serious damage to horse breeding. It is an agent of respiratory, reproductive and neurological disease outbreaks in young and adult equids. Viral envelope glycoprotein D (gD) is essential for binding and penetration into permissive cells and targeting the host immune system, inducing humoral and cellular immune responses, and is an appropriate antigen for use in vaccines and immunodiagnostics. The objective of this work was to express in Pichia pastoris and to characterize EHV-1 gD for later use as an antigen in immunodiagnostic techniques and formulation of recombinant vaccines. A DNA sequence encoding a truncated form of gDEHV-1 has been cloned into the P. pastoris expression vector pPICZαA. A protein of ~41 kDa was obtained as expected. The protein presented glycosylation between 4 kDa and 16 kDa, demonstrated by enzymatic deglycosylation. The recombinant protein was antigenically and immunogenically characterized by Western blot using equine polyclonal anti-EHV-1 antibodies, and by indirect ELISA in a murine model, demonstrating that the recombinant gD maintained epitopes similar to those of the native protein. These results suggest that gDEHV-1 is a promising antigen for use as an immunobiological in the control of EHV-1.(AU)


Asunto(s)
Animales , Pichia/aislamiento & purificación , Glicoproteínas , Herpesvirus Équido 1/aislamiento & purificación , Enfermedades Respiratorias/veterinaria , Caballos/virología
3.
Benef Microbes ; 9(1): 133-142, 2018 Jan 29.
Artículo en Inglés | MEDLINE | ID: mdl-29022386

RESUMEN

Probiotics modulate the immune response and can increase the effectiveness of vaccines. Bacillus toyonensis is widely used as a probiotic in animal feed. The aim of this study was to assess the effects of B. toyonensis administration on the immune response to an experimental recombinant vaccine against bovine herpesvirus type 5 (BoHV-5) in mice. Mice were vaccinated with BoHV-5 recombinant glycoprotein D and supplemented with the probiotic B. toyonensis in two regimes: one group received the probiotic only during seven days prior to the initial vaccination while the second group was given the probiotic throughout the experimental period of seven weeks. Animals supplemented with probiotic B. toyonensis in two regimes showed an increase in total immunoglobulin (Ig)G, IgG1 and IgG2a levels in serum, in addition to higher titres of antibodies capable of neutralising the BoHV-5 virus than non-supplemented animals (P<0.05). Splenocytes from the supplemented mice had higher mRNA transcription levels of cytokines interleukin (IL)-4 and IL-12. These results show that the use of this probiotic may significantly contribute to the response elicited by recombinant vaccines, especially those that rely on increasing antibody and cell-mediated immune responses for efficacy. Further, the data support an immunomodulatory effect for probiotic B. toyonensis and imply that enhance effect on the immune response against a BoHV-5 recombinant vaccine in mice.


Asunto(s)
Bacillus/inmunología , Herpesvirus Bovino 5/inmunología , Vacunas contra Herpesvirus/inmunología , Inmunomodulación/efectos de los fármacos , Probióticos/farmacología , Animales , Anticuerpos Neutralizantes/sangre , Anticuerpos Neutralizantes/inmunología , Citocinas/genética , Femenino , Regulación de la Expresión Génica/efectos de los fármacos , Vacunas contra Herpesvirus/administración & dosificación , Inmunoglobulina G/sangre , Inmunoglobulina G/inmunología , Factores Inmunológicos/administración & dosificación , Factores Inmunológicos/farmacología , Ratones , Probióticos/administración & dosificación , Vacunas Sintéticas/administración & dosificación , Vacunas Sintéticas/inmunología
4.
Hora vet ; 11(61): 8-10, maio-jun. 1991.
Artículo en Portugués | LILACS | ID: lil-114088

RESUMEN

No presente trabalho säo apresentados dados sobre a fasciolose bovina e ovina no município de Santa Vitória do Palmar, RS. O aparecimento de surtos graves da doença ocorridos nos últimos vinte anos foi associado à expansäo da área de arroz cultivada (344%), diminuiçäo do rebanho ovino (68%) e aumento do rebanho bovino (57%). Em um experimento a campo, dois terneiros traçadores colocados em resteva de arroz e abatidos após 33 dias mostraram no fígado a presença de 520 e 628 formas adultas de Faciola hepatica. Outros dois terneiros mantidos nas mesmas condiçöes, mas abatidos após 67 dias, mostraram presença de 359 e 282 formas adultas, respectivamente


Asunto(s)
Animales , Estudios de Cohortes , Bovinos , Ovinos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...